Published Online: Saturday, April 1, 2006

Although the generics industry promotes its products as therapeutically identical to higher-priced brand name drugs, newly published research now suggests that patient adherence to a therapeutic regimen is higher for patients on generics rather than branded drugs. The study, published in the February 13, 2006, issue of the journal Archives of Internal Medicine, concluded that patients given the generic version of a drug were found to adhere to their treatments better than those prescribed the brand name versions. "After controlling for patient sociodemographic characteristics and drug class, [the proportion of days covered] was 12.6% greater for patients initiated on generic medications," the researchers concluded.

Latest Articles
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.
Nasal corticosteroid sprays do not seem to be viable treatments for the common cold.
Latest Issues